Parkman Healthcare Partners’s KORU Medical Systems KRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-899,063
Closed -$3.1M 107
2023
Q2
$3.1M Buy
899,063
+47,688
+6% +$187K 0.54% 56
2023
Q1
$3.59M Buy
851,375
+128,319
+18% +$505K 0.78% 45
2022
Q4
$2.58M Buy
723,056
+39,590
+6% +$109K 0.69% 52
2022
Q3
$1.52M Buy
683,466
+8,032
+1% +$19.9K 0.43% 65
2022
Q2
$1.71M Buy
675,434
+2,977
+0.4% +$7.22K 0.63% 45
2022
Q1
$1.92M Buy
672,457
+74,847
+13% +$224K 0.56% 48
2021
Q4
$1.79M Buy
597,610
+371,354
+164% +$1.14M 0.4% 64
2021
Q3
$645K Buy
226,256
+25,000
+12% +$82.7K 0.16% 70
2021
Q2
$932K Sell
201,256
-60,466
-23% -$237K 0.2% 74
2021
Q1
$921K Sell
261,722
-439,537
-63% -$1.9M 0.21% 77
2020
Q4
$4.22M Buy
701,259
+70,033
+11% +$392K 1.08% 38
2020
Q3
$4.56M Sell
631,226
-90,759
-13% -$805K 1.21% 36
2020
Q2
$6.48M Buy
721,985
+150,000
+26% +$1.52M 1.83% 23
2020
Q1
$4.29M Buy
571,985
+43,413
+8% +$292K 1.99% 16
2019
Q4
$3.45M Buy
+528,572
New +$2.58M 1% 34

Other funds holding KRMD

Parkman Healthcare Partners's KRMD Position: Q3 2023 in Review

Parkman Healthcare Partners sold out of KORU Medical Systems (KRMD) in Q3 2023, closing a stake of 899,063 shares — an estimated $3.1M sold.

Parkman Healthcare Partners first reported a position in KRMD in Q4 2019 and held it in 15 quarters. The position peaked at $6.48M in Q2 2020. 55 funds tracked by Wall St. Rank hold KRMD as of Q3 2023.

  • Parkman Healthcare Partners reported no remaining KORU Medical Systems position as of Q3 2023 after selling out during the quarter.
  • Parkman Healthcare Partners sold 899,063 KORU Medical Systems shares in Q3 2023, an estimated $3.1M.
  • Parkman Healthcare Partners first reported a position in KORU Medical Systems in Q4 2019 and held it in 15 quarters.
  • Parkman Healthcare Partners's KORU Medical Systems position peaked at $6.48M in Q2 2020.
  • 55 funds tracked by Wall St. Rank held KORU Medical Systems as of Q3 2023.

Based on Parkman Healthcare Partners's 13F filing for Q3 2023, filed 14 Nov 2023.